Based on these results, we hypothesized that AMPK activation could be a common pathway involved in the phenomenon that occurs during thyroid tumour progression, when increased glucose uptake detected by 18F-FDG-PET is accompanied by decreased radioiodide uptake ability in DTC [14,15]. Here, PRKAA1 is linked to thyroid tumor.